[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100456075":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":22,"centralContacts":26,"locations":32,"responsibleParty":49,"collaborators":30,"id":51,"slug":30,"hasResults":52,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":30,"eligibilityCriteria":56,"healthyVolunteers":52,"sex":57,"minAge":58,"maxAge":59,"enrollmentInfo":60,"targetDuration":30,"studyType":63,"phases":64,"briefSummary":66,"conditions":67,"keywords":69,"overallStatus":34,"whyStopped":30,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":80},{"fullName":5,"class":6},"Children's Hospital Los Angeles","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"open label intervention arm","EXPERIMENTAL","Butyrate enemas will be administered once daily for twelve weeks.",[13],"Drug: Butyrate",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DRUG","Butyrate","Butyrate enemas will be administered once a day for 12 weeks",[9],[21],"Butyrate enemas",[23],{"name":24,"affiliation":5,"role":25},"Sonia Michail, MD","PRINCIPAL_INVESTIGATOR",[27],{"name":24,"role":28,"phone":29,"phoneExt":30,"email":31},"CONTACT","3233611353",null,"sonia.michail@hotmail.com",[33],{"facility":5,"status":34,"city":35,"state":36,"zip":37,"country":38,"countryCode":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"RECRUITING","Los Angeles","California","90027","United States","US",{"type":41,"coordinates":42},"Point",[43,44],-118.24368,34.05223,{"lat":44,"lon":43},[47],{"name":24,"role":28,"phone":48,"phoneExt":30,"email":31},"(323) 361-1353",{"type":25,"investigatorFullName":24,"investigatorTitle":50,"investigatorAffiliation":5,"oldNameTitle":30,"oldOrganization":30},"Principal Investigator","100456075",false,"NCT05218850","The Use of Butyrate Therapy in Pediatric Ulcerative Colitis","Butyrate Therapy in Hispanic Children With Ulcerative Colitis","Inclusion Criteria:\n\n* 7-21 years, mild to moderate ulcerative colitis\n\nExclusion Criteria:\n\n* UC therapy within 4 weeks of study medication initiation\n* infectious colitis, -pregnancy","ALL","7 Years","21 Years",{"count":61,"type":62},10,"ESTIMATED","INTERVENTIONAL",[65],"PHASE2","Butyrate is an important metabolite produced by the gut microbiome and has been shown as a helpful therapy in ulcerative colitis. This is a feasibility study to determine the efficacy of butryate enemas in pediatric ulcerative colitis.",[68],"Ulcerative Colitis",[70],"ulcerative colitis","2026-06-02",{"date":73,"type":74},"2026-06-04","ACTUAL",{"date":76,"type":74},"2022-06-29",{"date":78,"type":62},"2027-06-30",{"name":5,"class":6},1]